Transgenic (TG) mice deficient in glucocorticoid receptors (GR) were used in order to study the effects of a reduced GR function on adrenocorticotropin hormone and corticosterone plasma levels and on serotonin metabolism in different brain areas under basal resting conditions, after a 30-min restraint stress and 60 min after the end of the restraint stress. There was no difference in basal or stress-induced levels of either adrenocorticotropin hormone or corticosterone in control and TG mice, but the return of adrenocorticotropin hormone to basal values after the end of the stress was delayed in TG mice. Under basal conditions, the ratio 5-hydroxyindoleacetic acid/5-hydroxytryptamine was decreased only in the hippocampus of TG mice compared to controls. In the brain stem, the ratio 5-hydroxyindoleacetic acid/5-hydroxytryptamine increased compared to basal values after a 30-min restraint stress and values were still high 60 min after the end of the restraint stress in both control and TG mice. In the hippocampus, the ratio 5-hydroxyindoleacetic acid/5-hydroxytryptamine increased at the end of the stress and returned to basal levels 60 min later in control mice, whereas there was no change at the end of the stress but an increase 60 min later in TG mice. Finally there was no change in serotonin metabolism in the cortex, striatum or hypothalamus in either group or situation. Our results support the hypothesis of a tonic activation of serotonin turnover by corticosterone through GR in the mouse hippocampus. Moreover, stress-induced stimulation of serotonin metabolism in the brain stem and hippocampus appears to be delayed in TG mice compared to control mice. These results are particularly relevant for mood disorders such as depression where alterations of serotoninergic transmission might be secondary to an impairment of GR functions.

Keywords:
Serotonin, Adrenal steroid receptor, Stress, Transgenic mice, Brain stem, Hippocampus, Cortex, Corticotropin, Adrenal steroids, 5-hydroxyindoleacetic acid
1.
Nash JF, Meltzer HY, Lowy MT: The effect of adrenalectomy on NMDA-induced dopamine release in the striatum as measured by in vivo microdialysis and depletion of serotonin. Res Commun Subst Abuse 1992;13:177–190.
2.
Singh VB, Corley KC, Phan TH, Boadle-Biber MC: Increases in the activity of tryptophan hydroxylase from rat cortex and midbrain in response to acute or repeated sound stress are blocked by adrenalectomy and restored by dexamethasone treatment. Brain Res 1990;516:66–76.
3.
Azmitia EC, Algeri S, Costa E: In vivo conversion of 3H-L-tryptophan into 3H-serotonin in brain areas of adrenalectomized rats. Science 1970;169:201–203.
4.
De Kloet ER, Kovacs GL, Szabo G, Telegdy G, Bohus B, Versteeg DH: Decreased serotonin turnover in the dorsal hippocampus of rat brain shortly after adrenalectomy: Selective normalization after corticosterone substitution. Brain Res 1982;239:659–663.
5.
Van Loon GR, Shum A, Sole MJ: Decreased brain serotonin turnover after short-term (two-hour) adrenalectomy in rats: A comparison of four turnover methods. Endocrinology 1981;108:1392–1401.
6.
Chaouloff F: Regulation of 5-HT receptors by corticosteroids: Where do we stand? Fundam Clin Pharmacol 1995;9:219–233.
7.
Meijer OC, de Kloet ER: Corticosterone and serotonergic neurotransmission in the hippocampus: Functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 1998;12:1–20.
8.
Korte-Bouws GA, Korte SM, de Kloet ER, Bohus B: Blockade of corticosterone synthesis reduces serotonin turnover in the dorsal hippocampus of the rat as measured by microdialysis. J Neuroendocrinol 1996;8:877–881.
9.
Azmitia EC, McEwen BS: Adrenal-corticol influence on rat brain tryptophan hydroxylase activity. Brain Res 1974;78:291–302.
10.
Yanai J, Sze PY: Adrenal glucocorticoids as a required factor in barbiturate-induced changes in functional tolerance and brainstem tryptophan hydroxylase. Brain Res 1983;269:297–302.
11.
Gemma C, de Luigi A, de Simoni MG: Permissive role of glucocorticoids on interleukin-1 activation of the hypothalamic serotonergic system. Brain Res 1994;651:169–173.
12.
Singh VB, Phan TH, Corley KC, Boadle-Biber MC: Increase in cortical and midbrain tryptophan hydroxylase activity by intracerebroventricular administration of corticotropin releasing factor: Block by adrenalectomy, by RU 38486, and by bilateral lesions to the central nucleus of the amygdala. Neurochem Int 1992;20:81–92.
13.
Pepin MC, Pothier F, Barden N: Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 1992;355:725–728.
14.
Marchetti B, Peiffer A, Morale MC, Batticane N, Gallo F, Barden N: Transgenic animals with impaired type II glucocorticoid receptor gene expression: A model to study aging of the neuroendocrine-immune system. Ann NY Acad Sci 1994;746:308–327.
15.
Morale MC, Batticane N, Gallo F, Barden N, Marchetti B: Disruption of hypothalamic-pituitary-adrenocortical system in transgenic mice expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: Effects on T cell trafficking and T cell responsiveness during postnatal development. Endocrinology 1995;136:3949–3960.
16.
Barden N, Stec ISM, Montkowski A, Holsboer F, Reul JMHM: Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuroendocrinology 1997;66:212–220.
17.
Karanth S, Linthorst ACE, Stalla GK, Barden N, Holsboer F, Reul JMHM: Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology 1997;138:3476–3485.
18.
Stec I, Barden N, Reul JMHM, Holsboer F: Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatr Res 1994;28:1–5.
19.
Deakin JFW: A review of clinical efficacy of 5-HT1A agonists in anxiety and depression. J Psychopharmacol 1993;7:283–289.
20.
Holsboer F, Barden N: Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev 1996;17:187–205.
21.
Price LH: Serotonin reuptake inhibitors in depression and anxiety: An overview. Ann Clin Psychiatry 1990;2:165–181.
22.
Grino M, Guillaume V, Castanas E, Boudouresque F, Conte-Devolx B, Oliver C: Effect of passive immunization against corticotropin-releasing factor (CRF) on the post-adrenalectomy changes of CRF binding sites in the rat anterior pituitary gland. Neuroendocrinology 1987;45:492–497.
23.
Ratka A, Sutanto W, Bloemers M, de Kloet ER: On the role of brain mineralocorticoid (type-I) and glucocorticoid (type-II) receptors in neuroendocrine regulation. Neuroendocrinology 1989;50:117–123.
24.
Bradbury MJ, Akana SF, Dallman MF: Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: Evidence for a nonadditive effect of combined receptor occupation. Endocrinology 1994;134:1286–1296.
25.
Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JMHM, Landgraf R, Holsboer F: Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 1995;7:841–845.
26.
De Kloet ER, Reul JMHM: Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987;12:83–105.
27.
Reul JMHM, de Kloet ER: Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 1985;117:2505–2512.
28.
Pepin MC, Pothier F, Barden N: Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 1992;42:991–995.
29.
Telegdy G, Vermes I: Effect of adrenocortical hormones on activity of the serotoninergic system in limbic structures in rats. Neuroendocrinology 1975;18:16–26.
30.
Holmes MC, Yau JL, French KL, Seckl JR: The effect of adrenalectomy on 5-hydroxytryptamine and corticosteroid receptor subtype messenger RNA expression in rat hippocampus. Neuroscience 1995;64:327–337.
31.
Kizer JS, Palkovits M, Kopin IJ, Saavedra JM, Brownstein MJ: Lack of effect of various endocrine manipulations on tryptophan hydroxylase activity of individual nuclei of the hypothalamus, limbic system, and midbrain of the rat. Endocrinology 1976;98:743–747.
32.
Tejani-Butt SM, Labow DM: Time course of the effects of adrenalectomy and corticosterone replacement on 5-HT1A receptors and 5-HT uptake sites in the hippocampus and dorsal raphe nucleus of the rat brain: An autoradiographic analysis. Psychopharmacology 1994;113:481–486.
33.
Clement HW, Schafer F, Ruwe C, Gemsa D, Wesemann W: Stress-induced changes of extracellular 5-hydroxyindoleacetic acid concentrations followed in the nucleus raphe dorsalis and the frontal cortex of the rat. Brain Res 1993;18:117–124.
34.
Palkovits M, Brownstein M, Kizer JS, Saavedra JM, Kopin IJ: Effect of stress on serotonin concentration and tryptophan hydroxylase activity of brain nuclei. Neuroendocrinology 1976;22:298–304.
35.
Haleem DJ, Parveen T: Brain regional serotonin synthesis following adaptation to repeated restraint. Neuroreport 1994;5:1785–1788.
36.
Vahabzadeh A, Fillenz M: Comparison of stress-induced changes in noradrenergic and serotonergic neurons in the rat hippocampus using microdialysis. J Neurosci 1994;6:1205–1212.
37.
Dunn AJ: Stress-related changes in cerebral catecholamine and indoleamine metabolism: Lack of effect of adrenalectomy and corticosterone. J Neurochem 1988;51:406–412.
38.
Malyszko J, Takada Y, Urano T, Serizawa K, Kozima Y, Yan D, Takada A: Peripheral and central serotonergic systems in rats subjected to footshock or water-immersion restraint stress. Biogenic Amines 1994;10:303–310.
39.
Azmitia EC, Liao B, Chen Y-S: Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J Neurosci 1993;13:5041–5055.
40.
De Kloet ER, Versteeg DHG, Kovacs GL: Aldosterone blocks the response to corticosterone in the raphe-hippocampal serotonin system. Brain Res 1983;264:323–327.
41.
Linthorst ACE, Flachskamm C, Hopkins SJ, Hoadley ME, Labeur MS, Holsboer F, Reul JMHM: Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J Neurosci 1997;17:4448–4460.
42.
Dijkstra I, Tilders FJH, Aguilera G, Kiss A, Rabadan-Diehl C, Barden N, Karanth S, Holsboer F, Reul JMHM: Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function. J Neurosci 1998;18:3909–3918.
43.
Chaouloff F: Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 1993;18:1–32.
44.
Adell A, Casanovas JM, Artigas F: Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology 1997;36:735–741.
45.
Kirby LG, Alien AR, Lucki I: Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindole acetic acid. Brain Res 1995;682:189–196.
46.
Lazarova-Bakarova MB, Stancheva S, Petkova B, Genkova-Papasova M, Alova L, Boyanova E, Staneva-Stoytcheva D: Effects of beta-adrenoceptor blocker pindolol, calcium antagonist verapamil and their combination on retention in stew-down- and shuttle-box-trained rats and on brain biogenic monoamines. J Physiol (Paris) 1997;91:301–305.
47.
Culman J, Kiss A, Kvetnansky R: Serotonin and tryptophan hydroxylase in isolated hypothalamic and brain stem nuclei of rats exposed to acute and repeated immobilization stress. Exp Clin Endocrinol 1984;83:28–36.
48.
Oomagari K: Effects of morphine and diazepam pretreatment on immobilization stress-induced increase of serotonin metabolism in discrete brain areas of the rat. Fuk Iga Zas 1989;80:81–94.
49.
Shimizu N, Oomura Y, Aoyagi K: Electrochemical analysis of hypothalamic serotonin metabolism accompanied by immobilization stress in rats. Physiol Behav 1989;46:829–834.
50.
Paris JM, Lorens SA, Van de Kar LD, Urban JH, Richardson-Morton KD, Bethea CL: A comparison of acute stress paradigms: Hormonal responses and hypothalamic serotonin. Physiol Behav 1987;39:33–43.
51.
Heuser I, Yassouridio A, Holsboer F: The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatr Res 1994;28:341–356.
52.
Deakin JFW, Pennell I, Upadhyaha AJ, Lofhouse R: A neuroendocrine study of 5-HT function in depression: Evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacology 1990;101:85–92.
53.
McEwen BS, de Kloet ER, Rostene WH: Adrenal steroid receptors and actions in the nervous system. Physiol Rev 1986;4:1121–1188.
54.
Finlay JM, Zigmond MJ: A critical analysis of neurochemical methods for monitoring transmitter dynamics in the brain; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press, 1995.
© 1999 S. Karger AG, Basel
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.